However, TAM infiltration alone was not highly significant in prognostic analysis, while the presence of both CD68- and VEGF-expressing TAMs was predictive of better survival rates in stage II and stage III colon cancer patients [158]. The gene discussed is VEGFA; the disease is colonic neoplasm.